日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity.

IL-18 通过代谢重编程表达 CAR 的自然杀伤 T 细胞,增强其抗肿瘤活性。

Barragán Bravo Gabriel A, de la Cerda David A, Landoni Elisa, Dholakia Kshiti, Humeniuk Piotr, Caraballo Galva Leidy D, Wang Ying, Tian Gengwen, Yang Boning, Guo Linjie, Wood Michael S, Rios Xavier, Xu Xin, Courtney Amy N, Di Pierro Erica J, Jacob Joan, Li Yi-Han, Adaikkalavan Akshaya, Watanabe Norihiro, Mao Sufeng, Miles George, Dotti Gianpietro, Metelitsa Leonid S

Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15

神经母细胞瘤患者接受表达GD2特异性嵌合抗原受体和IL-15的自然杀伤T细胞治疗后出现白细胞增多症

Tian, Gengwen; Courtney, Amy N; Yu, Hangjin; Bhar, Saleh; Xu, Xin; Barragán, Gabriel A; Martinez Amador, Claudia; Ghatwai, Nisha; Wood, Michael S; Schady, Deborah; Montalbano, Antonino; Reddy, Shantan; Roche, Aoife M; de la Cerda, David; Parsons, Donald Williams; Di Pierro, Erica J; Bushman, Frederic D; Heczey, Andras; Metelitsa, Leonid S

Response to: Correspondence on "Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15" by Ataca Atilla and Atilla

回复:Ataca Atilla 和 Atilla 的来信“用表达 GD2 特异性嵌合抗原受体和 IL-15 的自然杀伤 T 细胞治疗神经母细胞瘤患者后出现白细胞增多症”。

Tian, Gengwen; Courtney, Amy N; Heczey, Andras; Metelitsa, Leonid S

Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells

嵌合抗原受体重定向NK T细胞的现状与前景

Courtney, Amy N; Zhou, Xin; Tian, Gengwen; Wang, Ying; Metelitsa, Leonid S; Dotti, Gianpietro

Refining chimeric antigen receptors via barcoded protein domain combination pooled screening.

通过条形码蛋白结构域组合混合筛选来优化嵌合抗原受体

Rios Xavier, Pardias Osmay, Morales Marc A, Bhattacharya Pradyot, Chen Yibin, Guo Linjie, Zhang Chunchao, Di Pierro Erica J, Tian Gengwen, Barragan Gabriel A, Sumazin Pavel, Metelitsa Leonid S

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma.

表达 GD2 特异性嵌合抗原受体和 IL15 的 NKT 细胞在体内表现出增强的持久性和抗神经母细胞瘤的抗肿瘤活性

Xu Xin, Huang Wei, Heczey Andras, Liu Daofeng, Guo Linjie, Wood Michael, Jin Jingling, Courtney Amy N, Liu Bin, Di Pierro Erica J, Hicks John, Barragan Gabriel A, Ngai Ho, Chen Yuhui, Savoldo Barbara, Dotti Gianpietro, Metelitsa Leonid S

IL-21 Selectively Protects CD62L(+) NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

IL-21 选择性地保护 CD62L(+) NKT 细胞并增强其在过继免疫疗法中的效应功能

Ngai Ho, Tian Gengwen, Courtney Amy N, Ravari Soodeh B, Guo Linjie, Liu Bin, Jin Jingling, Shen Elise T, Di Pierro Erica J, Metelitsa Leonid S

Correction for Hegazy et al., Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens

对 Hegazy 等人的论文《沙门氏菌 III 型分泌系统效应蛋白作为异源疫苗抗原载体的评估》的更正

Hegazy, Wael Abdel Halim; Xu, Xin; Metelitsa, Leonid; Hensel, Michael

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

具有嵌合抗原受体的不变性NKT细胞为安全有效的癌症免疫治疗提供了一个新的平台。

Heczey, Andras; Liu, Daofeng; Tian, Gengwen; Courtney, Amy N; Wei, Jie; Marinova, Ekaterina; Gao, Xiuhua; Guo, Linjie; Yvon, Eric; Hicks, John; Liu, Hao; Dotti, Gianpietro; Metelitsa, Leonid S

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma

转移性神经母细胞瘤中肿瘤相关炎症细胞的临床意义

Asgharzadeh, Shahab; Salo, Jill A; Ji, Lingyun; Oberthuer, André; Fischer, Matthias; Berthold, Frank; Hadjidaniel, Michael; Liu, Cathy Wei-Yao; Metelitsa, Leonid S; Pique-Regi, Roger; Wakamatsu, Peter; Villablanca, Judith G; Kreissman, Susan G; Matthay, Katherine K; Shimada, Hiroyuki; London, Wendy B; Sposto, Richard; Seeger, Robert C